Hereditary Angiodema (HAE)
Attune Pharmaceuticals is advancing therapies for Hereditary Angiodema (HAE), a rare and potentially life-threatening genetic condition characterized by recurring episodes of severe swelling.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal Nocturnal Hemoglobinuria (PNH) is an ultra-rare and life-threatening disease resulting from the chronic hemolysis of a patient’s red blood cells (RBCs).
Complement Pathway Inhibition
We've discovered small molecule inhibitors targeting complement system dysregulation in rare diseases.
On-Site Intern Training
This immersive program trains early-career professionals on:
- Clinical trial administration & documentation
- HIPAA- and GLP-compliant data integrity
- Quality assurance procedures
- Chain-of-command collaboration
Remote Onboarding Assessment (CCAP)
The CCAP is a secure, simulation-based remote screening protocol evaluating:
- Secure credential handling
- Protocol adherence
- HIPAA-compliant decision-making
- Check generation and procurement workflows